CN100490873C - Medicinal composition for treating high fever and preparation method thereof - Google Patents
Medicinal composition for treating high fever and preparation method thereof Download PDFInfo
- Publication number
- CN100490873C CN100490873C CNB200610109450XA CN200610109450A CN100490873C CN 100490873 C CN100490873 C CN 100490873C CN B200610109450X A CNB200610109450X A CN B200610109450XA CN 200610109450 A CN200610109450 A CN 200610109450A CN 100490873 C CN100490873 C CN 100490873C
- Authority
- CN
- China
- Prior art keywords
- radix
- hyperpyrexia
- preparation
- aspirin
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a pharmaceutical composition for treating high fever and process for preparation, which is prepared from raw material with the following constituents (by weight portions): ophiopogon root 7-20, hogfennel root 7.5-20, wofberry bark 10-31, talcum powder 8-28, aspirin 0.5-4, wolfberry fruit 5-18, ledebouriella root 7-22, and cimicifuga rhizome 7-21.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition for the treatment of hyperpyrexia (abbreviate as bring down a fever diffusing) and preparation method, relate in particular to a kind of pharmaceutical composition and preparation method of the hyperpyrexia that causes by SARS.
Background technology
Situation about can not bring down a fever in hospital is too numerous to mention at ordinary times, and this only is usual cat fever.Institute of hospital employing method is beaten back acupuncture with heated needle for to beat penicillin.Sars period in 2003, hyperpyrexia phenomenon still are serious, infect rapidly, are difficult to treatment control, because the complication of fever can not well be treated, cause a lot of an innocent persons' people to lose life.SARS mostly is Acute onset, generates heat to being first symptom, and body temperature is more than 38 degree, and it is high more to generate heat, and PD will be heavy more; Idol has a fear of cold, with or without headache, arthralgia and systemic pain, and chest pain or diarrhoea can be arranged.Also have tangible gradually respiratory symptom: dry cough, idol has sputum with blood streaks; Rapid breathing, tachypnea, uncomfortable in chest etc. appear in severe patient; Individual patients can further worsen, and develops into respiratory distress syndrome, causes respiratory failure.Thus, people still talk " allusion quotation " complexion changed up to now.Also there is not a kind of medicine can control the state of an illness separately at present.The pre-Seedling of SARS does not also formally enter the clinical practice stage.
Summary of the invention
At existing treatment hyperpyrexia, especially to being the inapparent technical deficiency of effect of drugs with hyperpyrexia of SARS symptom; Purpose of the present invention just is to provide a kind of pharmaceutical composition and preparation method for the treatment of hyperpyrexia, simultaneously, also is significantly to the hyperpyrexia therapeutic effect with SARS symptom.
For achieving the above object, the technical solution used in the present invention is:
A kind of pharmaceutical composition for the treatment of hyperpyrexia is characterized in that it is mainly by the preparation that comprises that following weight portion raw material components is prepared from: Radix Ophiopogonis 7-20, Radix Peucedani 7.5-20, Cortex Lycii 10-31, Talcum 8-28, aspirin 0.5-4, Fructus Lycii 5-18, Radix Saposhnikoviae 7-22, Rhizoma Cimicifugae 7-21.
Described raw material is following parts by weight of component: Radix Ophiopogonis 9-16, Radix Peucedani 9.5-15, Cortex Lycii 15-26, Talcum 9-21, aspirin 0.7-3, Fructus Lycii 7-15, Radix Saposhnikoviae 8.5-18, Rhizoma Cimicifugae 9-17.
Described raw material is following parts by weight of component: Radix Ophiopogonis 10.5, Radix Peucedani 13, Cortex Lycii 18, Talcum 18, aspirin 1, Fructus Lycii 8, Radix Saposhnikoviae 10, Rhizoma Cimicifugae 11.
Described preparation is pill, tablet, capsule.
A kind of preparation of drug combination method for the treatment of hyperpyrexia, may further comprise the steps: the weighting profit requires Radix Ophiopogonis, Radix Peucedani, Cortex Lycii, Fructus Lycii, Radix Saposhnikoviae, the Rhizoma Cimicifugae of one of 1-3 to mix, clean, sterilization, oven dry, add Talcum then, aspirin is pulverized together, makes pharmaceutical preparation at last routinely.
Introduce the effect of each raw material below:
Radix Ophiopogonis: YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire, and is used for dryness of the lung dry cough, the chronic consumptive disease cough, Tianjin wound is thirsty, vexed insomnia, interior-heat is quenched one's thirst.
Radix Peucedani: return lung, spleen channel, the wind heat clearing away of loosing, lowering the adverse-rising QI to resolve phlegm is used for the cough due to pathogenic wind-heat, abundant expectoration asthma, septum pectorale is full vexed.
Cortex Lycii: control asthenia hectic fever night sweat, the lung-heat cough with asthma is spitted blood, and quenches one's thirst, and the lung heat clearing pathogenic fire reducing is used for deficiency of YIN hectic fever, hectic fever due to YIN-deficiency night sweat, cough due to lung-heat.
Talcum: clearing away summer-heat and eliminating dampness, the summer-heat body is tired.
Aspirin: analgesicly bring down a fever, analgesia and antiinflammatory the formal name used at school aspirin.
Fructus Lycii: YIN nourishing invigorating the liver and kidney.
Radix Saposhnikoviae: inducing diaphoresis to dispel wind, win and wet, relieving convulsion.
Rhizoma Cimicifugae: deliver rash, heat-clearing and toxic substances removing, the elevate a turnable ladder yang-energy is used for headache due to pathogenic wind-heat, laryngopharynx swelling and pain, measles without adequate eruption.
The raw material that the present invention treats the pharmaceutical composition (it is diffusing to bring down a fever) of hyperpyrexia consists of: monarch: Radix Ophiopogonis, Radix Peucedani, Cortex Lycii, Talcum; Minister: aspirin; Assistant: Fructus Lycii, Radix Saposhnikoviae, Rhizoma Cimicifugae.
The function that the present invention treats the pharmaceutical composition (it is diffusing to bring down a fever) of hyperpyrexia cures mainly: cure mainly hyperpyrexia, can also treat the disease of flu one class.
The present invention controls pharmaceutical composition (it the is diffusing to bring down a fever) instructions of taking of hyperpyrexia: takes once for every, and 2 years old to 5 years old each 2 grams, 6 years old to 15 years old each 3 grams, 16 years old to each 4 grams of growing up.
But as hyperpyrexia interrupted (be several days burning person) again, can take the shake bile-fritillary end simultaneously when taking medicine of the present invention, produce as Foshan Fengliaoxing Pharmaceutical Co., Ltd., method is: take medicine of the present invention and take shake bile-fritillary end 8 grams, capsule after 3 hours; Took medicine of the present invention again in 3 hours again, spend 3 hours again and take the shake bile-fritillary end, like this each 3 times i.e. recoveries from illness.The elder must have wind because of the hyperpyrexia time, and wind is then gone into lung.And Fel Serpentis dispels the wind, and the tendril-leaved fritillary bulb cough-relieving treatment cardiopulmonary of coughing are so there is this effect.
The present invention has the following advantages;
1, the fever that flu is caused, clothes were once perspired and are brought down a fever in 20 minutes at the latest, and therapeutic effect is good; At least the hyperpyrexia (after bringing down a fever, also should at once change the treatment of primary symptom over to) evident in efficacy that SARS, cancer, leukemia, pneumonopathy are caused, the cure rate height has no side effect.
2, preparation method is simple, has reduced cost, and raw material sources conveniently are easy to get, and is with low cost.
Be the curative effect of proof medicine of the present invention, adopted the pharmaceutical composition (it is diffusing to bring down a fever) of treatment hyperpyrexia of inventor's following embodiment 3 to carry out zoopery and clinical trial.
One, zoopery:
(1) experiment source:
2005, World Health Organization (WHO) China office, just medicine of the present invention is done experiment on one's body from white mice.40 of the white mice that has SARS symptom that observation can be added up, white mice Mus age is that half a year is to a year and a half.
(2) experimental technique:
With mice infection SARS virus, fervescence fever and other SARS symptom appear in white mice.
Instructions of taking: medicine is made the injection injection, or sample food.Every white mice is taken once or injects once, and drug dosage is each 0.3 gram.
(3), experimental effect criterion:
Cure: the white mice temperature recovery is normal, and SARS symptom disappears, and physiological situation is normal.
Effectively: white mice is hyperpyrexia no longer, and SARS symptom obviously alleviates, and physiological situation is clearly better.
Invalid: do not bring down a fever, it is normal that physiological situation does not recover.
(4), laboratory observation result:
To 40 observation of curative effect of 14 days with white mice of SARS symptom, the result cures 39 of white mice, and effective 1, invalid 0, shared percentage ratio is respectively 97.5%, 2.5%, and 0.
Sum up:
Medicine of the present invention shows that through laboratory observation with regard to white mice, the cure rate total to the hyperpyrexia that has SARS symptom reaches 97.5%, and total effective percentage is 100%; This medicine has no side effect.
Two, case history source and typical analysis of medical record:
(1) case source:
Observation can be added up case 371 examples, wherein male 173 examples, women 198 examples, the oldest person 80 years old, reckling 1.5 years old.
(2) instructions of taking: pill, take once for every, 2 years old to 5 years old each 2 grams, 6 years old to 15 years old each 3 grams, 16 years old to each 4 grams of growing up.
(3), curative effect determinate standard:
Cure: various metabolism disorders recover normally fully, clinical symptom disappearance, clinical biochemical index ideal.
Effectively: clinical symptoms is clearly better, no longer hyperpyrexia cough, and various metabolism disorders obviously improve, and the clinical biochemical index is more satisfactory.
Invalid: clinical symptoms is not improved, and various metabolism disorders do not have change, do not reach " effectively " standard, and the clinical biochemical index is undesirable.
(4), observation of curative effect result:
To 371 routine cat fever patients' 7 days observation of curative effect, the result cures patient's 368 examples, effective patient's 3 examples, and invalid patient's 0 example, shared percentage ratio is respectively 99.19%, 0.81%, and 0.
Sum up:
Show that through clinical observation it reaches 99.19% to the total cure rate of cat fever, total effective rate is 100%; This medicine has no side effect, and cost is low, taking convenience.
In sum, the main component of medicine of the present invention has Radix Ophiopogonis, Radix Peucedani, Cortex Lycii, Talcum, aspirin, Fructus Lycii, Radix Saposhnikoviae, Rhizoma Cimicifugae.Medicine of the present invention is evident in efficacy to the hyperpyrexia that cold and high fever and SARS cause.
The specific embodiment
Embodiment 1
A kind of pharmaceutical composition (it is diffusing to bring down a fever) for the treatment of hyperpyrexia, sublimed preparation or pill:
Get following raw material (kg): Radix Ophiopogonis 7, Radix Peucedani 7.5, Cortex Lycii 10, Talcum 8, aspirin 0.5, Fructus Lycii 5, Radix Saposhnikoviae 7, Rhizoma Cimicifugae 7.
Preparation method: get above-mentioned Radix Ophiopogonis, Radix Peucedani, Cortex Lycii, Fructus Lycii, Radix Saposhnikoviae, Rhizoma Cimicifugae and mix, clean, sterilization, oven dry adds Talcum, aspirin then, is crushed to 420 order powder, makes sublimed preparation or pill then according to a conventional method.
Embodiment 2
A kind of pharmaceutical composition (it is diffusing to bring down a fever) for the treatment of hyperpyrexia, capsule:
Get following raw material (kg): Radix Ophiopogonis 20, Radix Peucedani 20, Cortex Lycii 31, Talcum 28, aspirin 4, Fructus Lycii 18, Radix Saposhnikoviae 22, Rhizoma Cimicifugae 21.
Preparation method: get above-mentioned Radix Ophiopogonis, Radix Peucedani, Cortex Lycii, Fructus Lycii, Radix Saposhnikoviae, Rhizoma Cimicifugae and mix, clean, sterilization, oven dry adds Talcum, aspirin then, is crushed to 100 order powder, makes capsule then according to a conventional method.
Embodiment 3
A kind of pharmaceutical composition (it is diffusing to bring down a fever) for the treatment of hyperpyrexia, tablet:
Get following raw material (kg): Radix Ophiopogonis 10.5, Radix Peucedani 13, Cortex Lycii 18, Talcum 18, aspirin 1, Fructus Lycii 8, Radix Saposhnikoviae 10, Rhizoma Cimicifugae 11.
Preparation method: get above-mentioned Radix Ophiopogonis, Radix Peucedani, Cortex Lycii, Fructus Lycii, Radix Saposhnikoviae, Rhizoma Cimicifugae and mix, clean, sterilization, oven dry adds Talcum, aspirin then, is crushed to 200 order powder, adds magnesium stearate 0.5kg, makes tablet then according to a conventional method.
Claims (5)
1, a kind of pharmaceutical composition for the treatment of hyperpyrexia is characterized in that the preparation that it is prepared from by following weight portion raw material components: Radix Ophiopogonis 7-20, Radix Peucedani 7.5-20, Cortex Lycii 10-31, Talcum 8-28, aspirin 0.5-4, Fructus Lycii 5-18, Radix Saposhnikoviae 7-22, Rhizoma Cimicifugae 7-21.
2, a kind of pharmaceutical composition for the treatment of hyperpyrexia according to claim 1, it is characterized by: described raw material is following parts by weight of component: Radix Ophiopogonis 9-16, Radix Peucedani 9.5-15, Cortex Lycii 15-26, Talcum 9-21, aspirin 0.7-3, Fructus Lycii 7-15, Radix Saposhnikoviae 8.5-18, Rhizoma Cimicifugae 9-17.
3, a kind of pharmaceutical composition for the treatment of hyperpyrexia according to claim 1, it is characterized by: described raw material is following parts by weight of component: Radix Ophiopogonis 10.5, Radix Peucedani 13, Cortex Lycii 18, Talcum 18, aspirin 1, Fructus Lycii 8, Radix Saposhnikoviae 10, Rhizoma Cimicifugae 11.
4, according to claim 1 or 2 or 3 described a kind of pharmaceutical compositions for the treatment of hyperpyrexia, it is characterized by: described preparation is pill, tablet, capsule.
5, a kind of preparation of drug combination method for the treatment of hyperpyrexia, may further comprise the steps: the weighting profit requires Radix Ophiopogonis, Radix Peucedani, Cortex Lycii, Fructus Lycii, Radix Saposhnikoviae, the Rhizoma Cimicifugae of one of 1-3 to mix, clean, sterilization, oven dry, add Talcum then, aspirin is pulverized together, makes pharmaceutical preparation at last routinely.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610109450XA CN100490873C (en) | 2006-08-16 | 2006-08-16 | Medicinal composition for treating high fever and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610109450XA CN100490873C (en) | 2006-08-16 | 2006-08-16 | Medicinal composition for treating high fever and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1907428A CN1907428A (en) | 2007-02-07 |
CN100490873C true CN100490873C (en) | 2009-05-27 |
Family
ID=37698765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200610109450XA Expired - Fee Related CN100490873C (en) | 2006-08-16 | 2006-08-16 | Medicinal composition for treating high fever and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100490873C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102366533A (en) * | 2011-08-20 | 2012-03-07 | 钱家美 | Pharmaceutical composition for treating hyperpyrexia and preparation method thereof |
-
2006
- 2006-08-16 CN CNB200610109450XA patent/CN100490873C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1907428A (en) | 2007-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1325083C (en) | Medicinal composition for removing dampness to relieve itching and its preparation method and uses | |
CN103610866B (en) | A kind of Chinese medicine of Hypertension | |
CN100490873C (en) | Medicinal composition for treating high fever and preparation method thereof | |
CN103142733B (en) | Chinese medicine composition for treating upper respiratory infection | |
CN104288477A (en) | Traditional Chinese medicine preparation curing infantile asthma | |
CN104623583A (en) | Asthenia cold abdominalgia treating drug and preparation method of asthenia cold abdominalgia treating drug oral liquid | |
CN102600343A (en) | Chinese medicinal preparation for treating oral diseases and/or toothache | |
CN101336990B (en) | Medicine for treating cholecystitis | |
CN102366533A (en) | Pharmaceutical composition for treating hyperpyrexia and preparation method thereof | |
CN104055920A (en) | Traditional Chinese medicine for treating infantile jaundice | |
CN103623369B (en) | A kind of Chinese medicinal formulae for the treatment of tonsillitis, chronic pharyngitis | |
CN102961682B (en) | Traditional Chinese medicine composition for clearing away heat and toxic materials | |
CN103656100B (en) | A kind of Chinese herbal medicine treating myocardial ischemia | |
CN102247494B (en) | External medicament for treating epidemic parotitis | |
CN101979056A (en) | Traditional Chinese medicament for treating asthma | |
CN106474405A (en) | A kind of Chinese medicine formula treating cough | |
CN101468069B (en) | Compound long pepper pain-relieving capsule | |
CN101357218B (en) | Externally used medicine for treating diabetes and preparation method thereof | |
CN105288095A (en) | Traditional Chinese medicinal composition for treating diabetes, and preparation method thereof | |
CN105902943A (en) | Medicine composition for treating wind heat cough of children | |
CN105497266A (en) | Traditional Chinese medicine for treating coronary heart disease | |
CN104998189A (en) | Traditional Chinese medicine powder for treating infantile oral ulcer of wind-heat spleen type and preparation method thereof | |
CN103638233A (en) | Traditional Chinese medicine composition for treating stomach fire up-flaming type periodontitis | |
CN110917328A (en) | Application of bupleuri radix, keel and oyster soup and Hua-Chao-Ku-Ge-Tang in preparation of medicine for treating anhidrosis-type hand-foot-and-mouth disease | |
CN104606636A (en) | Traditional Chinese medicine composition for treating depression and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090527 Termination date: 20120816 |